首页 | 本学科首页   官方微博 | 高级检索  
     

中药复方对冠心病治疗性血管新生的临床分析
引用本文:秦立,石海莉,黄捷,宋昆鹏,李艳,白起君. 中药复方对冠心病治疗性血管新生的临床分析[J]. 中医临床研究, 2014, 0(31): 22-23
作者姓名:秦立  石海莉  黄捷  宋昆鹏  李艳  白起君
作者单位:郑州大学附属郑州中心医院,河南郑州450000
摘    要:目的:观察并探讨中药复方对冠心病治疗性血管新生的作用。方法:选择实验用大鼠30只作为本次实验对象,将大鼠随机分为观察1组、观察2组与对照组3组,每组10只。观察1组作为中药组,观察2组为贝复济组,对照组为空白组。作大鼠心肌缺血实验模型,术后分别给药,观察3组大鼠EC、CD、VEGF及bFGF表达。结果:观察1组、观察2组大鼠CD与EC分布且与对照组比较,具有显著性差异(P〈0.05);观察1组与观察2组VEGF及bFGF反应与对照组比较,结果具有显著性差异(P〈0.05)。结论:中药复方可促进冠心病治疗性血管新生作用,其在临床上的应用还有待于进一步临床验证。

关 键 词:中药复方  冠心病  治疗性血管新生

A clinical analysis of treating coronary heart disease therapeutic angiogenesis in TCM medicine
Abstract:Objective:To observe and analyze clinical effects of TCM medicine on coronary heart disease therapeutic angiogenesis. Methods:30 rats were randomly divided into the observation group 1 (TCM medicine group), the observation group 2 (bFGF group) and the control group (blank group). Myocardial ischemia modes were made, EC,CD, VEGF and bFGF expression of rats in three groups were observed. Results: CD, EC distribution in the observation 1 and the observation 2 has statistically significant compared with the control group (P〈0.05);the same as VEGF and bFGF reactions (P〈0.05). Conclusion:TCM medicine can improve the function of coronary heart disease therapeutic angiogenesis, its application needs more examination.
Keywords:TCM combined medicine  Coronary heart disease  Therapeutic angiogenesis
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号